Mydriasis in a Parkinson's disease patient on low-dose carbidopa/levodopa

被引：0
|
作者：
Burdick, D. J.
Griffith, A.
Cole, A.
Sia, C. M.
Agarwal, P.
机构：
来源：
MOVEMENT DISORDERS | 2013年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
613
引用
收藏
页码：S218 / S218
页数：1
相关论文
共 50 条
  • [31] Levodopa/Carbidopa Enteral Suspension: A Review in Advanced Parkinson's Disease
    Hoy, Sheridan M.
    DRUGS, 2019, 79 (15) : 1709 - 1718
  • [32] DUODENAL CARBIDOPA/LEVODOPA: AN OPPORTUNITY FOR ADVANCED PARKINSON'S DISEASE PATIENTS
    Gayoso Rey, Monica
    Lopez Diaz, Luis Manuel
    ATENCION FARMACEUTICA, 2013, 15 (05): : 362 - 364
  • [33] Improvement of Primary Writing Tremor in Parkinson's Disease with Carbidopa/Levodopa
    Battista, James P.
    Greene, Paul E.
    TREMOR AND OTHER HYPERKINETIC MOVEMENTS, 2015, 5
  • [34] Continuous subcutaneous levodopa-carbidopa infusion for Parkinson's disease
    Moes, Harmen R.
    Buskens, Erik
    van Laar, Teus
    LANCET NEUROLOGY, 2024, 23 (09): : 856 - 857
  • [35] Crexont - Extended-Release Carbidopa/Levodopa for Parkinson's Disease
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2024, 66 (1718):
  • [36] Early morning akinesia in Parkinson's disease: Effect of standard carbidopa levodopa and sustained-release carbidopa levodopa
    Pahwa, R
    Lyons, K
    McGuire, D
    Dubinsky, R
    Hubble, JP
    Koller, WC
    NEUROLOGY, 1996, 46 (04) : 1059 - 1062
  • [37] First clinical experience with levodopa/carbidopa microtablets in Parkinson's disease
    Senek, M.
    Hellstrom, M.
    Albo, J.
    Svenningsson, P.
    Nyholm, D.
    ACTA NEUROLOGICA SCANDINAVICA, 2017, 136 (06): : 727 - 731
  • [38] Levodopa/Carbidopa Enteral Suspension: A Review in Advanced Parkinson’s Disease
    Sheridan M. Hoy
    Drugs, 2019, 79 : 1709 - 1718
  • [39] Dissolvable microarray patches of levodopa and carbidopa for Parkinson's disease management
    Anjani, Qonita Kurnia
    Moreno-Castellanos, Natalia
    Li, Yaocun
    Bin Sabri, Akmal Hidayat
    Donnelly, Ryan F.
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2024, 199
  • [40] Improved symptom control with fixed dose levodopa/carbidopa/entacapone versus conventional levodopa/carbidopa as first-line levodopa therapy in early Parkinson's disease (PD) patients
    Hauser, R. A.
    Panisset, M.
    Abbruzzese, G.
    Mancione, L.
    Dronamraju, N.
    Kakarieka, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 111 - 111
12345